Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

ReachLocal Inc. (RLOC): Are Hedge Funds Right About This Stock?

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The time period between June 25 and the end of October was one of those periods, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 14 percentage points. Given that the funds we track tend to have a disproportionate amount of their portfolios in smaller cap stocks, they have seen some volatility in their portfolios too. Actually, their moves are potentially one of the factors that contributed to this volatility. In this article, we use our extensive database of hedge fund holdings to find out what the smart money thinks of ReachLocal Inc. (NASDAQ:RLOC).

ReachLocal Inc. (NASDAQ:RLOC) has seen a decrease in hedge fund interest recently. At the end of this article, we will also compare ReachLocal Inc. (NASDAQ:RLOC) to other stocks, including Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS),, Inc. (NASDAQ:SPRT), and American Superconductor Corporation (NASDAQ:AMSC) to get a better sense of its popularity.

Follow Reachlocal Inc (NASDAQ:RLOC)
Trade (NASDAQ:RLOC) Now!

In the eyes of most shareholders, hedge funds are assumed to be underperforming, old investment vehicles of the past. While there are over 8000 funds trading today, Our researchers look at the elite of this group, around 700 funds. These hedge fund managers handle the bulk of the hedge fund industry’s total capital, and by shadowing their best investments, Insider Monkey has spotted a number of investment strategies that have historically surpassed the broader indices. Insider Monkey’s small-cap hedge fund strategy outperformed the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, let’s go over the new action encompassing ReachLocal Inc. (NASDAQ:RLOC).

How are hedge funds trading ReachLocal Inc. (NASDAQ:RLOC)?

At the end of Q3, a total of 6 of the hedge funds tracked by Insider Monkey held long positions in this stock, a decline of 14% from the previous quarter. With hedgies’ sentiment swirling, there exists a select group of noteworthy hedge fund managers who were boosting their holdings meaningfully (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Douglas T. Granat’s Trigran Investments has the biggest position in ReachLocal Inc. (NASDAQ:RLOC), worth close to $6.7 million, amounting to 2.1% of its total 13F portfolio. Coming in second is Renaissance Technologies, holding a $2 million position; less than 0.1% of its 13F portfolio is allocated to the stock. Other professional money managers that hold long positions encompass Steven Boyd’s Armistice Capital, D E Shaw, and Jose Fernandez’s Stepstone Group.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.